Home
>
National Drug Code (NDC)
>
Nimodipine
Nimodipine - 57664-135-65 - (Nimodipine)
Drug Information of Nimodipine
| Product NDC: | 57664-135 |
| Proprietary Name: | Nimodipine |
| Non Proprietary Name: | Nimodipine |
| Active Ingredient(s): | 30 mg/1 & nbsp; Nimodipine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Nimodipine
| Product NDC: | 57664-135 |
| Labeler Name: | Caraco Pharmaceutical Laboratories, Ltd. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077067 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20070628 |
Package Information of Nimodipine
| Package NDC: | 57664-135-65 |
| Package Description: | 100 BLISTER PACK in 1 CARTON (57664-135-65) > 1 CAPSULE in 1 BLISTER PACK (57664-135-60) |
NDC Information of Nimodipine
| NDC Code | 57664-135-65 |
| Proprietary Name | Nimodipine |
| Package Description | 100 BLISTER PACK in 1 CARTON (57664-135-65) > 1 CAPSULE in 1 BLISTER PACK (57664-135-60) |
| Product NDC | 57664-135 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Nimodipine |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20070628 |
| Marketing Category Name | ANDA |
| Labeler Name | Caraco Pharmaceutical Laboratories, Ltd. |
| Substance Name | NIMODIPINE |
| Strength Number | 30 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] |
